# OnCo record alphaparp (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/alphaparp/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "alphaparp" ;
  schema:name "AlphaPARP"@en ;
  schema:alternateName "[211At]PTT"@en, "211At-Parthanatine"@en, "Astatine-211 parthanatine"@en ;
  schema:description "AlphaPARP is an experimental radioactive drug from Trevarx Biomedical that carries an alpha-emitting atom to the DNA-repair enzyme PARP1 in cancer cells. It is being prepared for a first trial in ovarian cancer."@en ;
  schema:url <https://onco.cc/drugs/alphaparp/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.trevarx.com/>, <https://reporter.nih.gov/project-details/11408032> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Targeted alpha radiopharmaceutical (small molecule)" ;
  onco:technologies <https://onco.cc/technologies/astatine-211-alpha-therapy/>, <https://onco.cc/technologies/targeted-alpha-therapy/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:companies <https://onco.cc/companies/trevarx-biomedical/> .